Literature DB >> 24810554

Controversial clinical practices for patients with preeclampsia or HELLP syndrome: a survey.

Ahmet Basaran, Mustafa Basaran, Betul Basaran, Cihat Sen, James N Martin.   

Abstract

BACKGROUND: Considerable controversy continues to surround the management of severe preeclampsia and HELLP syndrome. Experts, researchers, and those published in the field were surveyed about their specific practices.
MATERIALS AND METHODS: An extensive literature search was undertaken to identify the cohort of authors with recent publications on the subjects of preeclampsia (2009-2012) and HELLP syndrome (2005-2012). Online surveys were sent to all authors using the email addresses found in their publications.
RESULTS: Surveys were delivered by email to 363 authors of preeclampsia publications and 91 authors of HELLP syndrome publications. Completed surveys were received from 61 (13.4%) of the group. Except for consensus about the indication of corticosteroids for the enhancement of fetal lung maturation, there was considerable variation in corticosteroid practice and anesthesia techniques.
CONCLUSIONS: A marked diversity in practice characterized the clinical care rendered by experts in the field of preeclampsia and HELLP syndrome. Thus, there is an urgent need for well-designed and executed prospective clinical trials to improve the evidence for best consensus practice in this area of obstetrical medicine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24810554     DOI: 10.1515/jpm-2014-0109

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  2 in total

1.  Anesthetic practices for patients with preeclampsia or HELLP syndrome: A survey.

Authors:  Betül Başaran; Bilge Çelebioğlu; Ahmet Başaran; Seher Altınel; Leyla Kutlucan; James N Martin
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-09-01

2.  Effectiveness of high-dose glucocorticoids on hemolysis, elevating liver enzymes, and reducing platelets syndrome.

Authors:  Suya Kang; Liping Zhou; Xiaoyan Wang; Yongmei Li; Yun Wang
Journal:  J Int Med Res       Date:  2018-11-19       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.